
Aug 13 (Reuters) – Zealand Pharma A/S: * SAID ON WEDNESDAY ENTERED INTO A USD 100 MILLION ROYALTY PURCHASE AND SALE AGREEMENT WITH ROYALTY PHARMA FOR THE ECONOMICS RELATED TO RUSFERTIDE Source text:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
German robot startup RobCo hits $1 billion valuation, CEO moves to US
AMSTERDAM, Oct 5 (Reuters) - German robotics maker RobCo on Monday said it had passed…
Ellison retains Thompson as CNN chief, unveils Skydance leadership team
Oct 5 (Reuters) - CNN chief executive Mark Thompson will remain chairman and editor-in-chief of…
Don't sugar the medicine: No dessert with antibiotics, doctors advise
Los Angeles (dpa) - Alexander Fleming’s discovery of penicillin 98 years ago paved the way…